Literature DB >> 19811274

Serum adipokine levels in patients with systemic lupus erythematosus.

Juan B De Sanctis1, Mercedes Zabaleta, Nicolás E Bianco, Jenny V Garmendia, Liliana Rivas.   

Abstract

In patients with systemic lupus erythematosus (SLE) metabolic alterations are often observed, which may be due to either the disease, the genetic background or the treatment. We studied the serum levels of the adipokines leptin, adiponectin, resistin, visfatin and ghrelin in patients with SLE and controls. Leptin levels were lower and adiponectin, ghrelin and visfatin levels were higher in the patients. No significant differences were encountered for resistin. The values of adipokines were independent of treatment, even after correction for body mass index. Inverse correlations were found among leptin and adiponectin, ghrelin and visfatin. We conclude that adipokines are involved in the metabolic imbalance of patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811274     DOI: 10.1080/08916930902828031

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  29 in total

1.  Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.

Authors:  Qing Huang; Sha-Sha Tao; Yu-Jing Zhang; Chao Zhang; Lian-Ju Li; Wei Zhao; Meng-Qin Zhao; Peng Li; Hai-Feng Pan; Chen Mao; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-05-03       Impact factor: 2.980

2.  Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus.

Authors:  Mary A Mahieu; Grace E Ahn; Joan S Chmiel; Dorothy D Dunlop; Irene B Helenowski; Pamela Semanik; Jing Song; Susan Yount; Rowland W Chang; Rosalind Ramsey-Goldman
Journal:  Rheumatol Int       Date:  2018-01-04       Impact factor: 2.631

3.  Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification.

Authors:  Joshua F Baker; Megan Morales; Mohammed Qatanani; Andrew Cucchiara; Eleni Nackos; Mitchell A Lazar; Karen Teff; Joan Marie von Feldt
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

4.  Resistin as a potential marker of renal disease in lupus nephritis.

Authors:  J Hutcheson; Y Ye; J Han; C Arriens; R Saxena; Q-Z Li; C Mohan; T Wu
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

Review 5.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

6.  Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.

Authors:  Kristopherson Lustosa Augusto; Eloisa Bonfa; Rosa Maria Rodrigues Pereira; Cleonice Bueno; Elaine Pires Leon; Vilma Santos Trindade Viana; Sandra Gofinet Pasoto
Journal:  Clin Rheumatol       Date:  2015-09-14       Impact factor: 2.980

7.  Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period.

Authors:  Vedat Gerdan; Ismail Sari; Didem Kozacı; Fatos Önen; Feride Yüksel; Ozgül Soysal; Dilek Solmaz; Necati Günay; Nurullah Akkoc; Servet Akar
Journal:  Rheumatol Int       Date:  2011-08-30       Impact factor: 2.631

8.  Analysis of adiponectin gene polymorphisms in Chinese population with systemic lupus erythematosus.

Authors:  Wen Liang Fang; Bin Zhou; Yan Yun Wang; Yu Chen; Lin Zhang
Journal:  J Biomed Biotechnol       Date:  2010-04-15

Review 9.  Association between leptin and systemic lupus erythematosus.

Authors:  Wang-Dong Xu; Min Zhang; Yu-Jing Zhang; Shan-Shan Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-05-11       Impact factor: 2.631

Review 10.  Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review.

Authors:  Elena Nikiphorou; George E Fragoulis
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-06-27       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.